studi
incid
infect
bordetella
pertussi
adult
present
prolong
dri
cough
spell
without
much
malais
mostli
without
fever
reproduc
shown
pertussi
account
case
even
vaccin
trial
acellular
pertussi
vaccin
adult
activ
surveil
cough
episod
last
week
around
caus
b
pertussi
therefor
wonder
agent
might
respons
prolong
cough
nonpertussi
case
opportun
address
question
data
set
origin
collect
gener
estim
popul
incid
adult
pertussi
germani
dataset
avail
biolog
sampl
allow
us
extend
diagnost
test
variou
pathogen
known
relat
acut
respiratori
infect
ari
contrast
pediatr
infect
caus
microorgan
adult
diseas
usual
primari
infect
symptom
reinfect
may
differ
almost
adult
outpati
respiratori
symptom
seen
gener
practition
gp
internist
diseas
requir
antibiot
treatment
wherea
caus
bordetella
spp
mycoplasma
spp
might
object
studi
describ
overal
burden
diseas
prolong
cough
adult
find
microorgan
contribut
prolong
cough
assess
whether
specif
clinic
symptom
could
distinguish
differ
agent
patient
recruit
gp
internist
work
gener
intern
medicin
summar
gp
krefeld
kr
rostock
hro
germani
studi
recruit
patient
octob
decemb
krefeld
octob
decemb
hro
time
total
patient
fulfil
inclus
criteria
studi
sentinel
hro
kr
studi
approv
ethic
committe
medic
board
kr
ethikkommiss
bei
der
nordrhein
lfd
nr
hro
ethikkommiss
bei
der
mecklenburgvorpommern
reg
nr
mv
lfd
nr
adult
patient
year
cough
day
sought
medic
attent
could
includ
patient
treat
chronic
respiratori
diseas
copd
exclud
patient
particip
studi
also
exclud
upon
request
ethic
committe
clinic
data
symptom
contact
durat
cough
collect
two
questionnair
second
sent
back
symptom
subsid
estim
populationbas
incid
sentinel
individu
report
overal
number
patient
treat
observ
period
total
randomli
select
patient
practic
electron
databas
will
contribut
subset
relev
treatment
data
collect
individu
analyz
avail
medic
record
respect
sentinel
three
author
ml
mr
chwvk
citi
hro
former
east
germani
mean
adult
year
popul
studi
period
kr
former
west
germani
mean
adult
popul
consult
number
statutorili
insur
patient
made
avail
vereinigungen
hro
kr
proport
privat
insur
patient
estim
hro
kr
studi
period
estim
consult
statutori
insur
privat
insur
hro
kr
statutori
insur
privat
insur
fig
estim
populationbas
incid
made
follow
assumpt
frequenc
patient
longer
last
cough
sentinel
would
gp
officesth
distribut
patient
prolong
cough
would
differ
gp
interniststh
relationship
patient
social
medic
insur
patient
privat
medic
insur
would
similar
sentinel
physician
physiciansth
number
patient
leav
enter
catchment
area
would
convers
sentinel
data
populationbas
incid
estim
carri
accord
method
suggest
strebel
et
al
briefli
shown
fig
extrapol
overal
studi
popul
individu
data
physician
conjunct
popul
consult
data
receiv
diagnost
sampl
total
patient
patient
fulfil
inclus
criteria
includ
owe
work
overload
physician
offic
lack
consent
patient
nasopharyng
swab
pharyng
wash
peripher
blood
sampl
taken
patient
first
present
sentinel
abl
perform
pcr
sampl
serolog
sampl
nasopharyng
swab
immers
modifi
ami
medium
charcoal
pharyng
wash
collect
steril
tube
sampl
transport
ambient
temperatur
laboratori
test
immedi
perform
sampl
frozen
nasopharyng
swab
test
bordetelladna
realtim
pcr
target
b
pertussi
b
parapertussi
pharyng
wash
test
adenoviru
dna
influenza
virus
b
human
metapneumoviru
rhinoviru
rna
inhous
realtim
pcr
throat
wash
pcr
inhibit
adenoviru
dna
pair
bp
fragment
hexon
gene
human
adenoviru
type
amplifi
influenza
viru
rna
fragment
gene
amplifi
revers
primer
degener
influenza
b
viru
rna
fragment
gene
amplifi
detect
human
rhinoviru
rna
fragment
region
genom
amplifi
second
primer
pair
ad
detect
addit
subtyp
human
metapneumoviru
rna
fragment
n
gene
use
primer
probe
rhinoviru
human
metapneumoviru
adapt
accord
sequenc
align
realtim
pcr
ct
valu
regard
neg
sampl
ct
valu
reanalyz
regard
posit
ct
valu
reproduc
pcrposit
sampl
regard
indic
agent
irrespect
serolog
result
serum
sampl
test
igg
iga
antibodi
adenoviru
igg
iga
antibodi
influenza
viru
b
igg
igm
antibodi
mycoplasma
pneumonia
iga
antibodi
human
parainfluenza
virus
igg
iga
antibodi
respiratori
syncyti
viru
rsv
use
elisa
virionserion
germani
igg
iga
antibodi
pertussi
toxin
pt
measur
use
inhous
elisa
interpret
serolog
commerci
elisa
measur
antibodi
quantit
arbitrari
unit
auml
cutoff
igg
elisa
viral
serolog
set
detect
antibodi
healthi
blood
donor
iga
antibodi
viral
antigen
andor
igm
antibodi
pneumonia
cutoff
also
regard
indic
recent
contact
igg
antipt
recommend
european
refer
laboratori
follow
iuml
igaantipt
iuml
regard
indic
recent
contact
irrespect
isotyp
antibodi
influenza
viru
influenza
viru
b
interpret
recent
contact
patient
report
vaccin
influenza
inform
influenza
vaccin
avail
calcul
statist
use
sa
version
sa
institut
cari
nc
usa
continu
outcom
normal
distribut
use
test
categor
outcom
use
pearson
chisquar
test
curv
plot
surviv
curv
depict
persist
cough
censor
criteria
stop
cough
particular
week
week
cough
beyond
week
consid
relat
pathogen
p
valu
consid
signific
outlin
fig
estim
overal
incid
longer
last
cough
adult
per
per
year
proport
smoker
studi
popul
smoke
smoke
provid
data
inform
durat
cough
patient
median
durat
cough
irrespect
pathogen
identifi
week
interquartil
rang
week
signific
differ
durat
cough
found
patient
kr
hro
durat
cough
differ
smoker
nonsmok
p
valu
fig
subgroup
patient
assess
medic
resourc
use
treatment
respect
gender
age
distribut
subgroup
statist
differ
overal
cohort
respect
gender
age
distribut
patient
total
contact
relat
cough
gp
mean
median
number
contact
per
patient
rang
total
sub
cohort
refer
anoth
specialist
ie
radiologist
chest
xray
n
ent
specialist
n
overal
patient
prescrib
type
drug
mostli
antibiot
antituss
mucolyt
agent
steroid
tabl
among
antibiot
macrolid
aminopenicillin
tetracyclin
prescrib
frequent
mani
patient
receiv
one
drug
antibiot
receiv
one
antibiot
identifi
possibl
infecti
caus
cough
patient
tabl
posit
pcr
found
case
posit
serolog
observ
case
probabl
posit
pcr
result
rang
human
metapneumoviru
adenoviru
similar
pathogen
test
overlap
ci
frequent
pathogen
identifi
serolog
adenoviru
rsv
b
pertussi
decreas
order
disjunct
ci
compar
pathogen
posit
test
mix
infect
occur
variou
combin
posit
test
found
frequent
adenoviru
plu
rsv
rsv
plu
b
pertussi
adenoviru
plu
pneumonia
accord
inclus
criteria
patient
cough
day
tabl
relat
symptom
patient
inform
symptom
avail
n
result
diagnost
test
pathogen
spectrum
patient
fill
questionnair
differ
overal
studi
cohort
shown
tabl
patient
cough
week
median
interquartil
rang
week
consult
physician
fever
found
averag
fever
fever
provid
data
report
choke
choke
choke
provid
data
none
report
symptom
patient
posit
test
significantli
differ
symptom
found
patient
neg
test
expect
fever
report
often
influenza
patient
similar
frequenc
also
rsv
patient
figur
show
surviv
analysi
patient
posit
test
adenoviru
rsv
b
pertussi
influenza
virus
mix
infect
posit
test
patient
posit
pathogen
exclud
overal
patient
infect
b
pertussi
seem
cough
longer
other
without
reach
signific
adult
pertussi
populationbas
incid
estim
patient
use
medic
resourc
vari
per
year
around
activ
surveil
sentinel
analyz
estim
populationbas
pertussi
incid
per
year
thu
burden
suffer
known
pertussi
unclear
prolong
cough
adult
affect
adult
popul
annual
condit
cumbersom
owe
median
durat
cough
week
substanti
burden
healthcar
system
half
patient
possibl
pathogen
could
identifi
test
use
studi
howev
patient
visit
physician
cough
week
median
thu
limit
clinic
relev
diagnost
find
therapeut
intervent
durat
cough
equal
smoker
nonsmok
proport
smoker
sampl
similar
report
microcensu
averag
durat
cough
consider
surpris
patient
visit
gp
frequent
drug
prescript
frequent
patient
receiv
drug
treatment
antibiot
antituss
steroid
recommend
infect
howev
probabl
longlast
symptom
patient
receiv
antibiot
antituss
steroid
retrospect
databas
analysi
drug
prescript
influenza
influenzalik
ill
much
shorter
durat
cough
germani
show
cohort
around
patient
receiv
prescript
howev
among
receiv
drug
receiv
antibiot
studi
receiv
antituss
studi
number
studi
link
pathogen
consid
analys
ari
adenoviru
outbreak
ari
young
adult
plagu
militari
time
recruit
usa
vaccin
adenoviru
pneumonia
mostli
associ
communityacquir
pneumonia
less
ari
prolong
cough
use
activ
surveil
szilagyi
et
al
found
caus
coronaviru
studi
rhinoviru
pcr
rsv
serolog
influenza
viru
pcr
serolog
metapneumoviru
pcr
adenoviru
pcr
serolog
sampl
howev
patient
healthcar
visit
anoth
us
studi
show
among
adult
febril
sever
ari
around
posit
viru
influenza
viru
rhinoviru
lead
caus
import
rhinoviru
also
stress
european
studi
point
role
reinfect
anoth
rhinoviru
type
link
laboratori
databas
telehealth
servic
data
uk
morbey
et
al
show
greatest
burden
ari
associ
influenza
rsv
rsv
patient
often
complain
cough
studi
establish
role
pathogen
prolong
adult
cough
diseas
similar
studi
depend
inclus
criteria
ari
everi
pathogen
account
rel
small
proport
case
therefor
target
diagnost
would
tempt
guidanc
clinic
symptom
possibl
unfortun
data
gave
hint
potenti
role
specif
clinic
symptom
either
agent
although
possibl
relev
pathogen
could
identifi
half
patient
diagnosi
late
effect
therapeut
intervent
patient
prolong
cough
consult
gp
median
week
onset
symptom
strength
studi
substanti
number
sentinel
physician
includ
use
two
citi
sampl
accord
studi
uk
cohort
also
show
higher
consult
rate
women
among
age
group
account
annual
variabl
circul
microorgan
studi
perform
three
winter
season
howev
limit
sentinel
consist
gp
internist
work
gp
thu
systemat
miss
patient
primarili
attend
specialist
pulmonologist
ent
specialist
age
distribut
differ
hro
kr
patient
hro
younger
kr
could
identifi
caus
use
nasopharyng
swab
b
pertussi
pcr
pharyng
wash
viral
pcr
nasopharyng
swab
recommend
pertussi
pharyng
wash
repres
nonoptim
materi
viral
pcr
patient
cough
median
week
visit
physician
overal
sensit
pcr
test
reduc
viral
shed
ie
rhinoviru
rsv
mostli
shorter
serolog
collect
acut
serum
sampl
could
show
titer
increas
would
improv
specif
diagnost
serolog
relev
pertussi
mycoplasma
infect
patient
igm
antibodi
pneumonia
assum
polyclon
respons
multipl
antigen
although
viral
serolog
sometim
regard
obsolet
recent
shown
appli
latent
class
analysi
valid
diagnost
method
absenc
gold
standard
singlesampl
viral
serolog
may
identifi
addit
case
regard
extern
valid
find
sampl
period
critic
respect
influenza
season
describ
moder
season
strong
season
moder
pertussi
occur
epidem
wave
notifi
case
pertussi
former
east
germani
indic
studi
carri
interepidem
period
therefor
possibl
proport
case
influenza
pertussi
might
higher
time
period
time
public
result
would
warrant
unfortun
data
analys
could
gener
substanti
delay
howev
reason
assum
invalid
find
conclus
data
show
prolong
adult
cough
requir
medic
attent
cumbersom
condit
prompt
substanti
healthcar
use
drug
prescript
broad
rang
pathogen
beyond
b
pertussi
associ
symptom
unfortun
patient
sought
medic
attent
late
diagnost
procedur
guid
efficaci
therapeut
intervent
